Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)
Clinical trial NCT02577029 · TERMINATED
Trial details
- NCT number
- NCT02577029
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2016-12-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.